12th April 2021 by Dr Louise Hudman
This is a new guideline from NICE advising that erenumab can be used for the prevention of migraine, published in March.
I did a blog a couple of months ago on galcanezumab, which was recently approved by NICE for the prevention of migraine, and erenumab has been approved for the same circumstances as galcanezumab.
It comes in two strengths: only the 140mg dose has been approved, as the 70mg dose wasn’t effective enough.
Brain tumours in general practice – diagnosis and referral
Shona Floyd of The Brain Tumour Charity shares her knowledge of leading research that affects referrals from general practice for diagnosing brain tumours.
‘Faster brain tumour diagnosis in GP’ scheduled for May NASGP webinar
An expert on primary care diagnostics for brain tumours will present NASGP’s May 2024 webinar, “Faster, better diagnosis of brain tumours for GPs”.
SIGN for migraine (March 2023)
Discover updates on use of the newer calcitonin gene-related peptide monoclonal antibodies and the use of medications during pregnancy.
"Booking GP locum sessions via LocumDeck's calendar is the best – plus, it's regularly updated. Support by the team is outstanding too, with Ali and Jacqui always ready to help."
Dr Raina Makhdoom, GP, Rayleigh, Essex